The American Academy of Neurology has recommended the use of blood thinners in patients with irregular heartbeat to lower the risk of stroke. The guidelines published in the journal Neurology say the novel blood thinners dabigatran, rivaroxaban and apixaban are less likely to cause bleeding in the brain than older treatments. These blood thinners may be used in patients with atrial fibrillation who were previously excluded due to old age, mild dementia or moderate risk of falls.

Related Summaries